logo for print

WuXi Waylaid

When Congress resumes next month, the BioSecure Act will be one of its top priorities. The bill, which could dramatically reorder the global pharmaceutical supply...

The Green Leap

From solar panels to electric vehicles, China dominates several of the technologies needed for the green energy transition. But can the U.S. find a way...

China’s Ozempic Test

Novo Nordisk, the maker of Ozempic, has enjoyed a China boom in recent years, commanding 77 percent of the market. But that kind of dominance...

Libel Lawfare

In recent years, several large Chinese companies have filed defamation suits against small organizations or individual researchers, leading to a strange reality: Even as the...

Broken Engagement

Our series of interviews with top U.S. policy makers of the last 30 years has revealed how and why the American approach towards China has...

A Son of Two Empires

In his new book, Edward Wong reflects on the nature of the American dream and the Chinese dream — and how he and his father...

The Clash of Constellations

In 2021, Beijing announced Guowang, its answer to SpaceX’s Starlink. But with very few updates about the project — apart from disciplinary inspections — it...